Mexico · Delayed Price · Currency is MXN Genomma Lab Internacional Statistics
Total Valuation
BMV:LAB.B has a market cap or net worth of MXN 14.28 billion. The enterprise value is 19.81 billion.
| Market Cap | 14.28B |
| Enterprise Value | 19.81B |
Important Dates
The next estimated earnings date is Wednesday, July 22, 2026.
| Earnings Date | Jul 22, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
BMV:LAB.B has 975.25 million shares outstanding. The number of shares has decreased by -1.83% in one year.
| Current Share Class | 975.17M |
| Shares Outstanding | 975.25M |
| Shares Change (YoY) | -1.83% |
| Shares Change (QoQ) | -0.84% |
| Owned by Insiders (%) | 31.01% |
| Owned by Institutions (%) | 28.06% |
| Float | 672.78M |
Valuation Ratios
The trailing PE ratio is 8.88 and the forward PE ratio is 6.95. BMV:LAB.B's PEG ratio is 0.84.
| PE Ratio | 8.88 |
| Forward PE | 6.95 |
| PS Ratio | 0.82 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | 10.06 |
| P/OCF Ratio | 7.22 |
| PEG Ratio | 0.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.90, with an EV/FCF ratio of 13.96.
| EV / Earnings | 12.35 |
| EV / Sales | 1.14 |
| EV / EBITDA | 4.90 |
| EV / EBIT | 5.39 |
| EV / FCF | 13.96 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.70.
| Current Ratio | 1.39 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 2.02 |
| Debt / FCF | 5.75 |
| Interest Coverage | 4.87 |
Financial Efficiency
Return on equity (ROE) is 14.05% and return on invested capital (ROIC) is 14.95%.
| Return on Equity (ROE) | 14.05% |
| Return on Assets (ROA) | 9.39% |
| Return on Invested Capital (ROIC) | 14.95% |
| Return on Capital Employed (ROCE) | 24.57% |
| Weighted Average Cost of Capital (WACC) | 5.49% |
| Revenue Per Employee | 10.55M |
| Profits Per Employee | 975,846 |
| Employee Count | 1,643 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 3.08 |
Taxes
In the past 12 months, BMV:LAB.B has paid 773.25 million in taxes.
| Income Tax | 773.25M |
| Effective Tax Rate | 32.54% |
Stock Price Statistics
The stock price has decreased by -31.82% in the last 52 weeks. The beta is 0.15, so BMV:LAB.B's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -31.82% |
| 50-Day Moving Average | 16.76 |
| 200-Day Moving Average | 17.95 |
| Relative Strength Index (RSI) | 35.54 |
| Average Volume (20 Days) | 3,530,838 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMV:LAB.B had revenue of MXN 17.33 billion and earned 1.60 billion in profits. Earnings per share was 1.65.
| Revenue | 17.33B |
| Gross Profit | 10.91B |
| Operating Income | 3.67B |
| Pretax Income | 2.38B |
| Net Income | 1.60B |
| EBITDA | 4.05B |
| EBIT | 3.67B |
| Earnings Per Share (EPS) | 1.65 |
Balance Sheet
The company has 2.63 billion in cash and 8.16 billion in debt, with a net cash position of -5.53 billion or -5.67 per share.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 8.16B |
| Net Cash | -5.53B |
| Net Cash Per Share | -5.67 |
| Equity (Book Value) | 11.72B |
| Book Value Per Share | 12.01 |
| Working Capital | 3.81B |
Cash Flow
In the last 12 months, operating cash flow was 1.98 billion and capital expenditures -557.21 million, giving a free cash flow of 1.42 billion.
| Operating Cash Flow | 1.98B |
| Capital Expenditures | -557.21M |
| Depreciation & Amortization | 372.83M |
| Net Borrowing | 1.12B |
| Free Cash Flow | 1.42B |
| FCF Per Share | 1.46 |
Margins
Gross margin is 62.98%, with operating and profit margins of 21.20% and 9.25%.
| Gross Margin | 62.98% |
| Operating Margin | 21.20% |
| Pretax Margin | 13.72% |
| Profit Margin | 9.25% |
| EBITDA Margin | 23.35% |
| EBIT Margin | 21.20% |
| FCF Margin | 8.19% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 5.46%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 5.46% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 48.76% |
| Buyback Yield | 1.83% |
| Shareholder Yield | 7.23% |
| Earnings Yield | 11.23% |
| FCF Yield | 9.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BMV:LAB.B is 25.40, which is 73.50% higher than the current price. The consensus rating is "Buy".
| Price Target | 25.40 |
| Price Target Difference | 73.50% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 5.90% |
| EPS Growth Forecast (3Y) | 16.26% |
Stock Splits
The last stock split was on August 3, 2010. It was a forward split with a ratio of 2.
| Last Split Date | Aug 3, 2010 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
BMV:LAB.B has an Altman Z-Score of 2.97 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.97 |
| Piotroski F-Score | 5 |